Advances in Targeted and Systemic Therapy for Salivary Gland Carcinomas: Current Options and Future Directions

Advances in Targeted and Systemic Therapy for Salivary Gland Carcinomas: Current Options and Future Directions

Salivary gland carcinomas (SGCs) represent a rare and heterogeneous group of malignancies accounting for 3–6% of all head and neck cancers. While surgical resection and radiotherapy remain the standard for locoregional control, systemic treatment is indicated for recurrent or metastatic disease. Adv...

Full description

Saved in:
Bibliographic Details
Main Authors: Sushanth Sreenivasan, Rahim A. Jiwani, Richard White, Veli Bakalov, Ryan Moll, Joseph Liput, Larisa Greenberg
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Current Oncology
Subjects:
salivary gland carcinoma
targeted therapy
head and neck tumors
immunotherapy
pleomorphic adenoma
chemotherapy
Online Access:https://www.mdpi.com/1718-7729/32/4/232
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items